Related Experiment Video

Updated: May 4, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

120

Does the existence of HCMV components predict poor prognosis in glioma?

Daling Ding1, Sheng Han, Zixun Wang

  • 1Department of Neurosurgery, The First Hospital of China Medical University, Nanjing Street 155, Heping District, Shenyang, 110001, China.

Journal of Neuro-Oncology
|January 8, 2014
PubMed

Insights

Human cytomegalovirus (HCMV) is present in gliomas, but its components do not impact patient prognosis. Further research is needed to understand HCMV's role in glioma development.

Area of Science:

  • Neuro-oncology
  • Virology
  • Molecular pathology

Background:

  • Malignant gliomas are aggressive brain tumors with poor prognoses.
  • Human cytomegalovirus (HCMV) has been implicated in glioma pathogenesis.
  • The precise role and prognostic significance of HCMV in gliomas remain unclear.

Purpose of the Study:

  • To investigate the presence of HCMV proteins (IE1-72, pp65) and DNA in glioma tissues.
  • To evaluate the prognostic value of detected HCMV components in glioma patients.
  • To compare HCMV presence in glioma tissues versus control brain samples.

Main Methods:

  • Immunohistochemical staining for HCMV proteins IE1-72 and pp65 in 67 glioma specimens.
  • Nested PCR to detect HCMV DNA in tumor tissues and patient peripheral blood.
  • Kaplan-Meier analysis and Cox proportional hazards models for prognostic evaluation.

Main Results:

  • HCMV proteins IE1-72 (76.1%) and pp65 (65.7%) were frequently detected in gliomas.
  • HCMV DNA was found in 52.2% of glioma tissues and 29.9% of peripheral blood samples.
  • No significant correlation was observed between HCMV presence and glioma patient prognosis.

Conclusions:

  • HCMV proteins and nucleic acids are prevalent in gliomas but do not serve as prognostic markers.
  • The findings suggest a complex relationship between HCMV and gliomas that requires further investigation.
  • The clinical relevance of HCMV in the context of malignant gliomas needs careful interpretation.

More Related Videos

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

15.6K
Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

9.2K

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
102
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K